Quick Search

  Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home

 
Brands
  Pharmacist Nutriceuticals®
  USA Best®
  USA LABORATORIES®
  USA SPORTS LABS®
Products
  Health Concerns
  Sexual Health
  Specialty Supplements
  Vitamins & Minerals
  --------------------------------------------
  Weight Loss
  --------------------------------------------
  Children's
  --------------------------------------------
  Female
  Male
  --------------------------------------------
  Sports & Athletic Nutrition
  Extreme Hardcore Body Building
  Body Shaping
  Amino Acids
  Proteins
  Carbohydrates
  --------------------------------------------
  Food Bars
  --------------------------------------------
  Branded Ingredients
  --------------------------------------------
  Press Releases
  --------------------------------------------
  Employment
  Company Policy
HEALTHY HEART™ [click to enlarge]
USALHH60T - 3#

MSRP: $29.99
Internet Direct: $24.99

Bottles:


60 Tablets
Pharmacist Recommended, CO-Q-10, Chitosan, Green Tea Extract and Much More!

Pharmacist References:


Coenzyme Q 10 References:
1. Weber C, Jakobsen TS, Mortensen SA, et al. Antioxidative effect of dietary coenzyme Q10 in humans blood plasma. Internat J Vit Nutr Res 1994;64:311-15.
2. Kelly GS. Sport nutriiton: a review of selected nutritional supplements for endurance athletes. Alt M Rev 1997;2:282-95.
3. Tanimura J. Studies on arginine in human semen. Part III. The influences of several drugs on male inferbility. Bull Osaka Med School 1967;12:90-100.
4. Gaby AR. Coenzyme Q10. In a Textbook of Natural Medicine, by JE Pizzomo, MT Murray, Seattle Bastyr University Press, 1998,V:CoQ10-1-8 [review].
5. Shigeta Y, Izumi K Abe H. Effect of coenzyme Q7 treament on blood sugar and ketone bodies of diabetics. J Vitaminol 1966;12:293-98.
6. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term coenzyme Q-10 therapy: a major advance in the management of resistant myocardial failure. Drug Exptl Clin Res 1985;11:581-93.
7. Morisco C, Trimarco B, Condorelli M. Effect of coenzyme Q10 in patients with congestive heart failure: a ling-term muliticenter randomized study. Clin Invest
1993;71:S134-36.
8. Gaby AR. The role of coenzyme Q10 in clinical medicine: part II. Cardivascular disease, hypertension, diabetes mellitus and infertitlty. Alt Med Rev 1996;1:168-75 [review].
9. Fujioka T, sakamoto Y, Mimua G. Clinical study of cardiac arhythmias using a 24-hour continous electrcardiographic recorder (5th report)--antirrhythmic action of coenzyme Q10 in diabetics. Tho J Exp Med 1983;14 9(suppl):453-63.
10. Kamikawa T, Kobayashi A, Yamashita T, et al. Effects of coenzyme Q10 on exercise tolerance in chronic stable angina pectoris. Am J Cardiol 1985;56:247.
11. Mortensen SA. Perspectives on therapy of cardiovascular diseases with coenzyme Q10 (ubiquinone). Clin Invest 1993;71:s116-23 [review}.
12. Tanaka J, Tominaga R, Yoshitoshi M, et al. Coenzyme Q10: the prophylactic effect on low cardio-output following cardiac value replacement. Ann Thorac Surg 1982;33:14551.
13. Folkers K, Wolaniuk J, Simonsen R, et al. Biochemical rational and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.Proc Natl Acad Sci 1985;82:4513-16.
14. Imagawa M, Naruse S, Tsuji S, et al. Coenzyme Q10, iron, and vitamin B6 in genetically-confirme Alzheimer's disease. Lancet 1992;340:671 [letter].
15. Folkers K, Shizukuishi S, Takemura K, et at. Increase in levels of IfF in serum of patients treated with coenzyme Q10. Res Comm Pathol Pharmacol 1982;38:335-38.
16. Lockwood K, Moesgaard S, yamamoto T, Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biphys Res Comm 1995;212:172-77.
17. Digiesi V, Cantini F, bisi G, et al. Mechanism of action of coenzyme Q10 in essential hypertensior Curr Ther Res 1992;51:668-72.
18. Weiss M, Mortensen SA, Rassig MR, et al. Bioavailabilty of four oral coenzyme Q10 formulations healthy volunteers. Molec Aspects Med 1994;15:273-80.
19. Kaikkonen J, Nyyssonen K, Porkkala-Sarataho E, et al. Effect of oral coenzyme Q10 on the oxidation resistance of human VLDL + LDL fraction: absorption and antixidative propertives of oil and granule-based preparations. Free Radic Biol Med
1997;22:1195-1202.
20. Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Ralative bioavailability of coenzyme Q10 formulations in human subjects. Internat J Vit Nutr Res 1998;68;109-13.
21. Larsson O. Effects of isoprenoids on growth of normal human mammary epithelial cells and breast cancer cells in vitro. Anticancer Res 1994;114:123-28.
22. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of coezyme Q10. Biochem Biophys Res Comm 1994;199:1504-1508.
23. Lockwood K, Moesgaard S, Yamamonto T. Folkers K. Progress on therapy of breast cancer with vitamin Q10 and the regression of metastases. Biochem Biophys Res Comm 1995;212:172-77.
24. Judy WV. Nutritional intervention in cancer prevention and treatment. American College for advancement in Medicine Spring Conference, Ft. Lauderdale, FL May 3, 1998.

Chitosan References:
1. Koide SS. Chitin-chiosan: properties, benefits and risks. Nutr Res 1998;1091-101 [review].
2. Maezaki Y, Tsuiji K, Nakagawa Y, et al. Hypochoslesterolemic effect of chitosan in adult males. Bios Biotech Biochem 1993;57:1439-44.
3. Jing SB, Li L, Ji D, et at. Effect of chitosan on renal function in patients with chronic renal failure. J Pharm Pharmacol
1997;49:721-23.
4. Deuchi K, Kanauchi O, Imasato Y, et al. Effect of the viscosity or deacetylation degree of chitosan fecal fat exvreted from rats fed on a high-fat diet. Biosci Biotech Biochem 1995;59:781-85.
5. Deuchi, K, Kanauchi O, Imasato Y, et al. Decreasing effect of chitosan on the apparent fat digestible by rats fed on a high-fat diet. Biosci Biotech Biochem 1994;58:1613-16.
6. Kanauchi O, Deuchi K, Imasato Y, et al. Increasing effect of a chitosan and ascorbic acid mixture fecal dietary fat excretion. Biosci
Biot tec Biochem 1994;54:1617-20.
7. Deuchi K, Kanauchi O, Schizukuishi M, et al. Continuous and massive intake of chitosan affects mineral and fat-soluble vitamin status in rats fed on a high-fat diet. Biosci Biotech Biochem 1995;59:1211-16.
8. Kato H, Taguchi T, Okuda H, et al. Antihypertensive effect of chitosan in rats and humans. J Trad Medicinen 1994;11:198-205.
9. Terada A, Hara H, Sato D, et al. Effect of dietary chitosan on faecal microbiota and faecal metabolic of humans. Micro Ecol Health Dis 1995;8:15-21.
10. Bone E, Tamm A, Hill M. The production of urinary phenols by gut bacteria and their possible role the causation of large bowel cancer. Am J Clin Nutr 1976;29:1448-54.

Hawthorn References:
1. Rewerski VW, Piechoscki T, et al. Some pharmacological properties of oligomeric procyanidin isolated from hawthorn (Crataegus oxyacantha). Arzeim-Forsch Drug Res 1967;17:490-91.
2. Weiki A, Noh HS. The influence of Crataegus on global cardiac insufficiency. Herz Gefabe 1993;11:516-24.
3. Bahorun T, trotin F, et al. Antioxidant activities of Crataegus monogyna extracts. Planta Med 1994;60:323-28.
4. Weihmayr T, Ernst E. Therapeutic effectiveness of Crataegus. Fortschr Med 1996;114(1-2):27-29 [German].
5. Schmidt U, Kugn U, Ploch M, Hubner W-D. Efficacy of the Hawthorn (Crataegus) preparatoin Ll1: in 78 patiients with chronic congestive heart failure defined as NYHA functional class II. Phytomed 1994;1(1):17-24.
6. Taucvhert M, Ploch M, Hubner WD. Effectiveness of hawthorn extract Ll132 compared with the inhibitor Captopril: Multicenter double-blinde study with 132 patients NYHA stage II. Numch Med Wochesnschr 1994;132(supp):S27-33.
7. Hanack T, Bruckel M-H. The treatment of mild stable forms of angina pectoris using Crataegutt (R) Novo. Tharapiewoche 1983;33:4331-33 [in German].
8. Brown DJ. Herbal Prescritptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 139-44.

Chromium References:
1. Saner G, Yüzbasiyan V, Neyzi O, et al. Alterations of chromium metabolism and effect of chromium supplementation in Turner's syndrome patients. Am J Clin Nutr 1983;38:574-78.
2. Riales R, Albrink MJ. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men. Am J Clin Nutr 1981;34:2670-78.
3. Wang MM, Fox EZ, Stoecker BJ, et al. Serum cholesterol of adults supplemented with brewer's yeast or chromium cholride. Nutr Res 1989;9:989-98.
4. Page TG, Ward TL, and Southern LL. Effect of chromium picolinate on growth and carcass characteristics of growing-finishing pigs. J Animal Sci 1991;69:356.
5. Lefavi R, Anderson R, Keith R, et al. Efficacy of chromium supplementation in athletes: Emphasis on anabolism. Int J Sport Nutr 1992;2:111-22.
6. McCarty MF. The case for supplemental chromium and a survey of clinical studies with chromium picolinate. J Appl Nutr 1991;43:59-66.
7. Hallmark MA, Reynolds TH, DeSouza CA, et al. Effects of chromium and resistive training on muscle strength and body composition. Med Sci Spt Ex 1996;28:139-44.
8. Kaats GR, Blum K, Fisher JA, Adelman JA. Effects of chromium picolinate supplementation on body composition: a randomized, double-masked, placebo-controlled study. Curr Ther Res 1996;57:747-51.
9. Kaats GR, Blum K, Pullin D, Keither SC, Wood R. A randomized, double-masked, placebo-control study of the effects of chromium picolinate supplementation on body composition: a replication and extension of a previous study. Curr Ther Res 1998;59:379-88.
10. Sterns DM, Belbruno JJ, Wetterhahn KE. A prediction of chromium (III) accumulation in humans from chromium dietary supplements. FASEB J 1995;9:1650-57.
11. Sterns DM, Wise JP, Patierno SR, Wetterhahn KE. Chromium (III) picolinate produces chromosl damage in Chinese hamster ovary cells. FASEB J 1995;9:1643-49.
12. Garland M, Morris JS, Colditz GA, et al. Toenail trace element levels and breat cancer. AmJ Epidemiol 1996;144:653-60.
13. Cerulli J, Grabe DW, Guathier I, et al. Chromium picolinate toxicity. Ann Pharmacother 1998;32:428-31.
14. Wasser WG, Feldman NS. Chromic renal failure after ingestion of over-the-counter chromium picolinate. Ann Intern Med 1997;126:410 [letter].
15. Offenbacher EG. Promotion of chromium absorption by ascorbic acid. Trace Elements Electrolyte 1994;11:178-81.

Green Tea References:
1. Graham HN. Green tea composition, consumption, and polyphenol chemistry. Prev Med 1992;21:334-50.
2. Kono S, Shinchi K, Ikeda N, et al. Green tea consumption and serum lipid profiles: A cross-section study in Northen Kyushu, Japan. Prev Med 1992;21:526-31.
3. Yamaguchi Y, Hayashi M, Yamazoe H, et al. Preventive effects of green tea extract on lipid abnormallties in serum, liver and aorta of mice fed an atherogenic diet. Nip Yak Zas 1991;97(6):329-
4. Sagesaka-Mitane Y, Milwa M, Okada S. Platelet aggregation inhibitors in hot water extract of green tea. Chem Pharm Bull 1990;38(3):790-93.
5. Stensvold I, Tverdal A, Solvoll K, et al. Tea consumption. Relationship to cholesterol, blood pressure and coronary and total mortality. Prev Med 1992;21:546-53.
6. Tsubono Y, Ysugane S. Green tea intake in relation to serum lipid levels in middle-aged Japanese men and women. Ann Epidemiol 1997;7:280-84.
7. Serafini M, Ghiselli A, Ferro-Luzzi A, In vivo antioxidant efffect of green tea in man. Eur J Clin Nutr 1996;50:28-32.
8. Van het Hof KH, de Boer HSM, Viseman SA, et al. Consumption of green or black tea does not invrease resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997;66:1125-3.
9. Stoner GD, Mukhtar H. Polyphenols as cancer chemoprentive agents. J Cell Bioch 1995;22:169-80.
10. Yor SQ. Study on feasibity of Chinese green tea polyphenois (CTP) for preventing dental caries. Chin J Stom 1993;28(4):197-99.
11. Hamilton-Miller JM. Antimicrobial properties of tea (Camellia sinensis L). Antimicro Agents Chemother 1995;39(11):2375-77.
12. Imai K, Nakachi K. Cross sectional study effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995;310:693-96.
13. Murrary MT. The Healing Power of Herbs. Rocklin, CA: Prima Publishing, 1995, 192-96.

Lecithin References:
1. Benjamin J, Levine J. Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. Am J Psychiatry 1995;152:1084-86.

Calcium References:
1. Osborne CG, McTyre RB, Dudek J, et al. Evidence for the relationship of calcium to blood pressure Nutr Rev 1996;54:365-81.
2. Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patrients with ileal disease and with renal and absorptive hypercalciurias: effect of calcium and magnesium. Am J Med 1978;64:579-85.
3. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-83.
4. Bell L, Hastenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 1992;152:2441-44.
5. Sheihk MS, Santa Ana CA, Nicar MJ, et al. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
6. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev 1994;52:221-32 [review].
7. Nicar MJ, Pak CYC. Calcium bioavailability from calcium carbonate and calcium citrate. J Clin Endocrinol Metabo 1985;61:391-93.
8. Harvey JA, Kenny P, Poindexter J, pak CYC. Superior calcium absorption from calcium citrate than calcium carbonate using external forearm counting. J Am Coll Nutr 1990;9:583-87.
9. Sheikh MS, Santa Ana CA, Nicar MJ, et at. Gastrointestinal absorption of calcium from milk and calcium salts. N Engl J Med 1987;317:532-36.
10. Epstein O, Kato Y, Dick R, Sherlock S. Vitamin D, hydroxyapatite, and calcium gluconate in treatment of cortical bone thinning in postmenopausal women with primary billiary cirrhosis. Am J Clin Nutr 1982;36:426-30.
11. Heaney RP, Recker RR, Weaver CM. Absorbability of calcium sources: the limited role of solubitt Calcif Tissue Int 1990;46:300-4.
12. Deroisy R, Zartarian M, Meurmans L, et al. Acute changes in serum calcium and parathyroid hormaone circulating levels induced by the oral intake of five currently available calcium salts in healthy male volunteers. Clin Rheumatol 1997;16:249-53.
13. Burros M. Testing calcium supplements for lead. New York Times June 4, 1997,B7.
14. Bourgoin BP, Evans DR, Cornett JR, et al. Lead content in 70 brands of dietary calcium supplements. Am J Publ Health 1993;83:1155-60.
15. Civitelli R, Villareal DT, Agnusdei D, et al. Dietary L-lysine and calcium metabolism in humans. Nutrition 1992;8:400-5.
16. Flodin NW. The metabolic roles; pharmacology, and toxicology of lysine. J Am Coll Nutr 1997;16:7-21 [rview].

L-carnitine References:
1. Mancini M, Rengo F, Lingetti M, Sorrentino GP, Nolfe G. Controlled study on the therapeutic effica of propionyl-L-carnitine in patients with congestive heart failure. Arzneimittelforschung 1992;42:1101-
2.Giamberardino MA et al. Effects of prolonged L-carnitine adminstration on delayed muscle pain an CK release after eccentric effort. Int J Sports Med 1996;17:320-24.
3. Green RE, Levine AM, Gunning MJ. The effect of L-cartine supplementation on lean body mass male amateur body builders. J AM, Dietet Assoc 1997;(syook):A-72.
4. Murray MT. The many benefits of carnitine. Am J Natural Med 1996;3:6-14 [review].
5. Dal Negro R, Pomari G, et al. L-carnitine and rehabilitative respiratory physiokinesitherapy: metabo and ventilatory response in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol 1986;24:453-56.
6. Dal Negro R, Turco P, Pomari C, De Conti F. Effects of L-carnitine on physical performance in chronic respiratory insufficiency. Int J Clin Pharmacol Ther Toxicol 1988;26:269-72.
7. Dipalma JR. Carnitine deficiency. Am Family Phys 1988;38:243-51.
8. Kendler BS. Carnitine: an overview of its role in preventive medicine. Prev Med 1986;15:373-90.
9. Del Favero A. Carnitine and gangliosides. Lancet 1988;ii:337 [letter].
10. Kobayashi A, Masumura Y, Yamazaki N. L-carnitine treatment for congestive heart failure-experimental and clinical study. Jpn Circ J 1992;56:86-94.

Ginger References:
1. Tyler VE. Herbs of Choice: The Therapeutic Use of Phytomedicinals. Binghamton, NY: Pharmaceutical Products Press, 1994, 39-42.
2. Bradley PR, ed. British Herbal Compendium, vol 1. Bournemouth, Dorset, UK: British Herbal medicine Association, 1992, 112-14.
3. Yamahara J, Huang Q, et al. Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull 1990;38:430-31.
4. Al-Yahya MA, Rafatullah S, et al. Gastroprotective activity of ginger in albino rats. Am J Chinese Med 1989;17:51-56.
5. Holtmann S, Clarke AH, et al. The anti-motion sickness mechanism of ginger. Acta Otolaryngol (Stockh) 1989;108:168-74.
6. Suekawa M, Ishige A, et al. Pharmacological studies on ginger. I. Pharmacological actions of pung constituents, (6)-gingerol and (6)-shogaol. J Pharm Dyn 1984;7:836-48.
7. Bone ME, Wilkinson DJ, Young JR, et al. Ginger root -a new antiemetic: The effect of ginger root postoperative nausea and vomiting after major gynaecological surgery. Anaethesea 1990;45:669-7
8. Phillips S, Ruggier R, Hutchinson SE. Zingiber officinale (ginger) -an antiemetic for day case surgery. Anaesthesia 1993;48:715-17.
9. Visalyaputra S, Petchpaisis N, Somcharoen K, Choavaratana R. The efficacy of ginger root in the prevention of postoperative nausea and vomiting after outpatient gynaecological laparoscopy. Anaesthesia 1998;53:506-10.
10. Grontved A, Brask T, Kambskard J, Hentzer E. Ginger root against seasickness. Acta Otolaryngo 1988;105:45-49.
11. Meyer K, Schwartz J, Craer D, Keyes B. Zingiber officinale (ginger) used to prevent 8-Mop associated nausea. Dermatol Nursing 1995;7:242-44.
12. Langer E, Greifenberg S, Gruenwald J. Ginger: History and use. Adv Ther 1998;15:25-44 [review].
13. Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber officinale Rosc) and fenugreek (Trigonella foenumgraecum L) on blook lipids, blood sugar, and platelet aggregation in patients with coronary artery disease. Prostagland Leukotrienes Essential Fatty Acids 1997;56:379-84.
14. Lumb AB. Effect of dried ginger on human platelet function. Thromb Haemoost 1994;7:110-11 .
15. Janssen PL, Meyboom S, van Staveren WA, et al. Consumption of ginger (Zingiber officinale Roscoe) does not affect ex vivo platelet thromboxane production in humans. Eur J Clin Nutr 1996;50:772-74.
16. Verma SK, Singh J, et al. Effect of ginger on platelet aggregation in man. Indian J Med Res 1994;98:240-42.
17. Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 111-18.
18. Blumenthal M, Busse WR, Goldberg A, et al, eds. The Complete Commission E Monographs: Therapeutic Guide to Herbal Medicines. Boston, MA: Intergrative Medicine Communications, 1998,135-36.

Selenium References:
1. Clark LC, Combs GF, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. JAMA 1996;276:1957-63.
2. Yoshizawa K, Wilett WC, Morris SJ, et al. Study of prediagnostic selenium levels in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 1998;90:1219-24.
3. Yu S-Y, Li W-G, Zhu Y-J, et a. Chemoprevention trial of human hepatitis with selenium supplementation in China. Biol Trace Element Res 1989;20:15-20.
4. Peretz A, Neve J, Desmedt J, et al. Lymphocyte response is enhanced by supplementation of elde subjects with selenium-enriched yeast. Am J Clin Nutri 1991;53:1323-28.
5. Scott R, Mocpherson A, Yates RWS, et al. The effect of oral selenium supplementation on human sperm motitlity. Br J Urol 1998;82:76-80.
6. Dworkin BM. Selenium deficiency in HIV infection and the acquired immunodeficiency syndrome (AIDS). Chem Biol Iteract 1994;91:181-869.
7. Moore JA, Noiva R, Wells IC. Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 1984;30:1171-73.
8. Contempre B, Dumont JE, Ngo B, et al. Effects of selenium supplementation in hypothyroid subject of an iodine and selenium deficient area: The possible danger of indiscriminate supplementation of iodine deficient subjects with selenium. J Clin Endocrinol Metabol 1991;73:213-15.

Vitamin B1 References:
1. Cheraskin E, Ringsdorf WM, Medford FH, Hicks BS. The "ideal" daily vitamin B1 intake Oral Med 1978;33:77-79.


  • Back To List
  • Wholesaler/Distributor Registration   l  My Cart   l   My Account  l  Home  l  Return to Top of Page

        Nasvhille Chamber of Commerce Dickson County Chamber of Commerce U.S. Commercial Service

    *These statements have not been evaluated by the F.D.A. *USA Laboratories makes no representation or warranties concerning the use of our products for the diagnosis, cure, mitigation, treatment or prevention of any disease. *Seek advice from a health care provider before using this or any supplement product.

    Powered By LionZone Copyright © USA LABORATORIES, INC. All rights reserved.